Definitive Contract 36C25723C0049
Award Date 2/9/23
Potential Completion Date 8/8/23
Potential Value $888K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Temple, TX 76504, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a $1.13 million firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 on December 1, 2023, with performance extending through November 30, 2026. The contract, which carries no set-aside designation, calls for the supply of radiopharmaceutical products to support nuclear medicine diagnostic and therapeutic imaging services. The...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) awarded a $822,867.94 firm fixed-price delivery order to RLS (USA) Inc. for radiopharmaceutical products, effective September 18, 2024, with an ultimate completion date of September 18, 2025. This delivery order represents a task order issued under RLS (USA) Inc.'s larger Indefinite Delivery Contract (IDC) with VA VISN 17, which carries a ceiling value of approximately $5 million and extends through...
- This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $356,461.75 by the Department of Veterans Affairs Veterans Integrated Service Network 5 for the supply of radiopharmaceuticals. The contract, awarded on April 1, 2025, carries a firm fixed price structure and an ultimate completion date of March 31, 2026. Performance will be executed from the contractor's facility in Lake Mary, Florida. This delivery order does not carry a set-aside designation and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 on January 1, 2026, for the supply of radiopharmaceuticals for nuclear medicine patients. The contract carries a firm fixed-price ceiling value of $493,958.37 with an ultimate completion date of December 31, 2026, and will be performed in Lake Mary, Florida. This delivery order is not designated as a set-aside contract and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a $505,759.50 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 12 for the supply of nuclear medicine radiopharmaceuticals. The award, effective January 1, 2026, through December 31, 2026, supports the Edward J. Hines, Jr. VA Hospital in Hines, Illinois, and addresses the facility's Nuclear Medicine Clinic requirements for unit...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to RLS USA Inc. for the provision of radiopharmaceutical products and services. The contract value is $461,329.26 to be delivered to the Olin E. Teague Veterans' Medical Center in Temple, Texas from September 2020 through December 2021. Under the contract, the contractor will produce medical isotopes from non-highly enriched uranium...
- RLS USA Inc. was awarded a $244,564.67 firm fixed price delivery order against an unspecified multiple award contract vehicle to provide radiopharmaceutical products to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The one year contract, which contains no set-aside designation and is to be completed by September 13, 2023, will support the VA's efforts to serve veterans in the Lake Zurich, Illinois area through the delivery of...
RLS USA Inc., a foreign-owned, for-profit organization, has been awarded a definitive contract valued at $888,053.37 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The firm fixed price contract is for the delivery of radiopharmaceuticals with a period of performance through August 8, 2023. No set-aside designation was applied to this award to fulfill the VA's requirement for these medical isotopes. Place of performance will be in Temple, Texas. The contract utilizes no large multiple award vehicle and was competitively awarded to support healthcare services for veterans through the VA network in central Texas.
Generated 1/23/24, 3:51 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Radiopharmaceuticals for Temple Texas VA Medical Center | 36C25723C0049_1 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Limited / Sole Source Justification 1/1 | 2/21/23, 1:45 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($2k) | 1/22/24 | |
| Not listed | Not listed | $445.0k | 2/10/23 |